EW - India's Meril files EU antitrust complaint against Edwards: report
2024-05-13 11:11:20 ET
More on Edwards Lifesciences
- Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
- Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript
- Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
- Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M
- Edwards Lifesciences Q1 2024 Earnings Preview